Skip to search formSkip to main contentSkip to account menu

tideglusib

Known as: 4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Recent FDA action (through, August/September 2010) related to Luveniq, Motavizumab, Ceftaroline fosamil, Dabigatran etexilate…